World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 2 September 2019
Main ID:  ISRCTN13406789
Date of registration: 16/02/2018
Prospective Registration: No
Primary sponsor: Food for Health Ireland
Public title: Postprandial cheese matrix study
Scientific title: Post-prandial randomised controlled trial to examine the postprandial effects of dairy fat within different matrices
Date of first enrolment: 01/02/2018
Target sample size: 10
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN13406789
Study type:  Interventional
Study design:  Single-centre randomised cross-over intervention trial (Other)  
Phase:  Not Applicable
Countries of recruitment
Ireland
Contacts
Name: Emma    Feeney
Address:  UCD Centre for Molecular Innovation and Drug Discovery Science Centre South, Belfield D04 V1 W8 Dublin Ireland
Telephone:
Email:
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Fasting triglycerides <2.5
2. BMI 18-35

Exclusion criteria:
1. Familial hypercholesteraemia
2. Fasting triglycerides greater than 2.5
3. Any diagnosed metabolic disorder such as diabetes type 1 or 2


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Blood lipids
Nutritional, Metabolic, Endocrine
Intervention(s)

Subjects will receive three meals which contain dairy fat in varying levels of a cheese matrix, with a slice of toast as a carrier, in a random order with a 5-7 day washout period in between meals. Due to the nature of the meals, the arms cannot be masked.

Arm 1: 120g full fat cheddar cheese and a slice of low-fibre white toast
Arm 2: 120g reduced fat cheddar cheese and a slice of low-fibre white toast
Arm 3: 30g calcium caseinate powder
Primary Outcome(s)
Circulating fatty acids measured with a Randox Daytona from blood samples collected at fasting, and hourly, on the hour, for the 6-hour postprandial period
Secondary Outcome(s)
Blood glucose measured with a Randox Daytona from blood samples collected at fasting, and hourly for the 6-hour post-prandial period
Secondary ID(s)
LS-17-103
Source(s) of Monetary Support
Enterprise Ireland
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Human Research Ethics Committee in University College Dublin, 24/01/2018, ref. LS-17-103
Results
Results available: Yes
Date Posted:
Date Completed: 31/08/2018
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history